Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
October 27, 2015
Patent Application Number
13992253
Date Filed
December 8, 2011
Patent Primary Examiner
Patent abstract
The invention provides cycloalkyl guanidine compounds that inhibit F1F0-ATPase, and methods of using cyclalkyl guanidine compounds as therapeutic agents in therapy, such as treating an immune disorder, inflammatory condition, or cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
